Yeji
FDA approvalconf 0.70

voxzogo — FDA approval

$BMRN · BIOMARIN PHARMACEUTICAL INC
Event date
Date TBD
Sponsor runway
cash-flow +
$2.22B liquid

Evidence

“BioMarin was awarded the PRV in November 2021 when the FDA granted accelerated approval to VOXZOGO™ (vosoritide) for injection, indicated to increase linear growth in pediatric patients with achondroplasia five years of age and older with open epiphyses (growth plates).”
Source: 8-K filed 2022-02-14View on EDGAR ↗0001048477-22-000005

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

2 insiders · 0 buys · 1 sells
Tax
2026-05-20
Hubbard Cristin
EVP, Chief Commercial Officer
2,318 @ $50.20$116K
Sell
2026-05-07
Friberg Gregory R
EVP, Chief R&D Officer
3,281 @ $53.85$177K
← All catalysts for $BMRN